An update on β-lactamase inhibitor discovery and development
JD Docquier, S Mangani - Drug Resistance Updates, 2018 - Elsevier
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
An update on β-lactamase inhibitor discovery and development.
JD Docquier, S Mangani - Drug Resistance Updates: Reviews and …, 2017 - europepmc.org
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
[引用][C] An update on β-lactamase inhibitor discovery and development
JD Docquier, S Mangani - Drug Resistance Updates, 2018 - cir.nii.ac.jp
An update on β-lactamase inhibitor discovery and development | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[PDF][PDF] An update on β-lactamase inhibitor discovery and development.
JD Docquiera, S Manganib - 2023 - academia.edu
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
An update on β-lactamase inhibitor discovery and development
JD Docquier, S Mangani - DRUG RESISTANCE UPDATES, 2018 - usiena-air.unisi.it
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
An update on β-lactamase inhibitor discovery and development.
JD Docquier, S Mangani - 2018 - cabidigitallibrary.org
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
An update on β-lactamase inhibitor discovery and development
JD Docquier, S Mangani - Drug Resistance Updates, 2018 - orbi.uliege.be
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
An update on β-lactamase inhibitor discovery and development
JD Docquier, S Mangani - Drug resistance updates …, 2018 - pubmed.ncbi.nlm.nih.gov
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
[PDF][PDF] An update on β-lactamase inhibitor discovery and development.
JD Docquiera, S Manganib - 2023 - usiena-air.unisi.it
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …
threatens our capability to treat bacterial diseases, including potentially deadly hospital …